Wright Medical Group to Buy BioMimetic for About $380M

Spinal Tech
Heather Linder -

Medical device manufacturer Wright Medical Group has agreed to purchase BioMimetic Therapeutics for up to $380 million, according to Memphis Business Journal. Wright Medical will pay $190 million in cash and stock for BioMimetic, which produces regenerative medicine products for bone and tissue repair. Contingent payments of up to $190 million may be made, pending FDA approval of a new BioMimetic product.  

More Articles on Devices:
Smith & Nephew Appoints Julie Brown as CFO
Medtronic Acquires Chinese Orthopedic Device Company for $755M
24 Spine Devices Receive FDA 510(k) Clearance in October




Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.